Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Patent
1995-06-26
1998-07-28
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
4242791, 4242801, 4242831, 536 111, 5361231, A61K 4500
Patent
active
057859752
ABSTRACT:
The present invention relates to phospholipid-polysaccharide adjuvant compositions and to vaccine formulations comprising same, as well as to methods of making and using such adjuvants and vaccines.
REFERENCES:
patent: 4185090 (1980-01-01), McIntire
patent: 4981684 (1991-01-01), MacKenzie et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5091187 (1992-02-01), Haynes
patent: 5091188 (1992-02-01), Haynes
patent: 5189028 (1993-02-01), Nikl et al.
patent: 5246707 (1993-09-01), Haynes
patent: 5256328 (1993-10-01), Cavanagh et al.
patent: 5298262 (1994-03-01), Na et al.
patent: 5302401 (1994-04-01), Liversidge et al.
Carbohydrate Chemistry, ed. Kennedy, J., Clarendon Press, Oxford, 1988, pp. 259-260.
The Carbohydrates, Chemistry and Biochemistry, Second Edition, ed. Pigman, W. et al., Academic Press, New York, 1970, pp. 348-349.
Chitin, Chitosan, and Related Enzymes, ed. Zikakis, J.P., Academic Press, Inc., Orlando, 1984, pp. xx and xxi.
Lockoff, Agnew Chem Int Ed Eng 30, pp. 1611-1620, 1991.
Stryer, "Biochemistry" W.H. Freeman & Company, NY, USA pp. 213-215 and 782-784, 1981.
Keitel et al, Vaccine, vol. 11(9) pp. 909-913, 1993.
Ullrich et al, J. of Leukocyte Biology, vol. 52, pp. 489-494, 1992.
Bakalyar Heather A.
Hultquist Steven J.
Hutzell Paula K.
Research Triangle Pharmaceuticals
LandOfFree
Adjuvant compositions and vaccine formulations comprising same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adjuvant compositions and vaccine formulations comprising same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant compositions and vaccine formulations comprising same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-21041